Hypomanic mood in a child patient treated with interferon-alpha 2a: case report
Related Experiment Videos
1Division of Child Neurology and Psychiatry, Department of Pediatrics, University of Catania,Via S. Sofia, 78, 95123 Catania, Italy. mazzone@unict.it
Insights
Interferon-alpha 2a therapy for chronic hepatitis B in a child led to hypomanic mood and seizures. Early psychiatric evaluation and intervention are crucial for managing these side effects during treatment.
Area of Science:
- Pediatric Gastroenterology
- Child Psychiatry
- Hepatology
Background:
- Chronic hepatitis B infection is a significant global health concern in children.
- Interferon-alpha 2a (IFN-alpha 2a) is a therapeutic option for chronic hepatitis B.
- Psychiatric side effects of IFN-alpha 2a therapy in pediatric populations require further investigation.
Observation:
- A 10-year-old male child with chronic hepatitis B developed hypomanic mood and psychogenic seizures approximately 30 days after initiating IFN-alpha 2a treatment.
- Psychological assessment revealed symptoms including hyperactivity, distractibility, excessive talkativeness, grandiosity, and racing thoughts.
- The child exhibited heightened emotionality as a temperamental trait.
Findings:
- The patient's psychiatric symptoms were successfully managed with risperidone and cognitive-behavioral therapy.
- The IFN-alpha 2a treatment resulted in a positive clinical outcome for chronic hepatitis B after six months.
- This case highlights the potential for affective disturbances in children undergoing IFN-alpha 2a therapy.
Implications:
- Pediatricians and hepatologists should be vigilant for psychiatric adverse events during IFN-alpha 2a treatment.
- Early psychiatric evaluation and appropriate therapeutic interventions are essential for children receiving IFN-alpha 2a.
- Understanding and managing IFN-induced psychiatric symptoms can improve treatment adherence and outcomes in pediatric hepatitis B.
Abstract:
We report on a male child born in Rumania, adopted by an Italian family, and who at 10 years of age was submitted to interferon-alpha 2a therapy for chronic hepatitis B. About 30 days after the beginning of the treatment he developed hypomanic mood and psychogenic seizures. Psychological evaluation showed hyperactivity, distractibility, excessive talkativeness, grandiosity and racing thoughts. Temperamental traits were characterized by an elevated emotionality. The patient was successfully administered risperidone and cognitive-behavioral therapy; six months of treatment with interferon led to positive outcome of hepatitis B. Since affective symptoms may occur in children treated with IFN, a careful evaluation of psychiatric disturbances and adequate intervention are needed.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Inhibitors of Viral Protein Synthesis
Bipolar Disorder
Cytomegalovirus Disease
Factors Affecting Illness
For instance, risk factors are connected to illness, disability,...